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Interaction between FGF and BMP
signaling pathways regulates
development of metanephric mesenchyme
Andrew T. Dudley,1,2 Robert E. Godin,1 and Elizabeth J. Robertson3
Department of Molecular and Cellular Biology, Harvard University, The Biological Laboratories,
Cambridge, Massachusetts 02138 USA

Nephrogenesis in the mouse kidney begins at embryonic day 11 and ends ∼10 days postpartum. During this
period, new nephrons are continually being generated from a stem-cell population—the nephrogenic
mesenchyme—in response to signals emanating from the tips of the branching ureter. Relatively little is
known about the mechanism by which the nephrogenic mesenchyme cell population is maintained at the tips
of the ureter in the presence of signals promoting tubulogenesis. Previous studies have shown that a loss of
Bmp7 function leads to kidney defects that are a likely result of progressive loss of nephrogenic mesenchyme
by apoptosis. The studies presented here demonstrate that BMP7 signaling can prevent apoptosis in explants
of metanephric mesenchyme. The surviving mesenchyme cell population, however, is not competent to
respond to signals promoting tubulogenesis. In conjunction with FGF2, BMP7 promotes growth and maintains
competence of the mesenchyme in vitro. In addition, FGF2 and BMP7 signaling, both independently and in
combination, inhibit tubulogenesis. Interestingly, FGF2 and BMP7 also promote expansion of the stromal
progenitor cell population in whole kidney culture. Because BMP7 is not produced by stromal progenitor cells,
these data suggest a novel interaction between the nephrogenic mesenchyme and stromal progenitor cell
populations. A model for the regulation of nephrogenesis by FGF and BMP signaling is presented.
[Key Words: Kidney; fibroblast growth factor; bone morphogenetic protein-7; stromal progenitor cell;
apoptosis; competence]
Received January 5, 1999; revised version accepted April 27, 1999.

Development of the metanephric kidney depends on a
program of reciprocal inductive interactions between
two mesodermal derivatives, the ureteric bud and the
nephrogenic mesenchyme (for review, see Saxen 1987).
During the eleventh day postcoitum (dpc), the ureteric
bud, an outgrowth of the Wolffian duct, contacts the
metanephric blastema. Following contact, inductive interactions establish two cell fates within the blastema—
the stromal progenitor cells and the nephrogenic mesenchyme (Aufderheide et al. 1987). Signals from the ureteric bud promote survival of the nephrogenic
mesenchyme and initiate in this cell population a process leading to tubule formation. Concomitantly, signals
provided by the mesenchyme stimulate growth and
branching of the ureteric bud that ultimately forms the
collecting duct system. Continued development of the
metanephros is dependent on coordination of these two
processes.
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Little is known about the signals involved in maintaining a population of nephrogenic mesenchyme at the
tips of the branching ureter. Preserving this cell population conceptually requires three signaling events. First,
the tendency of metanephric mesenchyme to undergo
apoptosis must be blocked (Weller et al. 1991; Koseki et
al. 1992; Coles et al. 1993). Second, because branching of
the ureter and formation of nephrons subdivides and depletes the nephrogenic mesenchyme cell population, self
renewal via cell proliferation is necessary (Sainio et al.
1994). Third, a signal is required to oppose tubulogenesis
promoted by the ureter, thereby reserving a subset of
cells for future rounds of tubulogenesis. It is likely that
at least some of these signals are downstream of Emx2, a
transcription factor expressed in the ureter (Miyamoto
et al. 1997). In Emx2 null mutant embryos, the ureter
contacts the blastema but fails to promote survival or
proliferation of the mesenchyme. In part, this may be
attributable to failure of the mutant ureter to induce
robust expression of certain genes, such as the transcription factors Wilms’ tumor gene-1 (WT1) and Pax2, in the
adjacent metanephric mesenchyme (Dressler et al. 1990;
Kreidberg et al. 1993). Analysis of null mutants demonstrated that WT1 function is required cell autonomously
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for response of the mesenchyme to signals emanating
from the ureter (Kreidberg et al. 1993). Genes downstream of Emx2 and WT1 may include receptor tyrosine
kinases (RTK) and their respective ligands, such as members of the fibroblast growth factor (FGF) gene family.
One member of the family, FGF2/bFGF, prevents apoptosis and promotes expression of WT1 in cultures of isolated rat metanephric mesenchyme (Perantoni et al.
1995a). Following treatment, these explants remain
competent to undergo tubulogenesis in response to signals from spinal cord (Barasch et al. 1997). It is likely that
FGF family members have several roles during metanephric development, as their receptors (FGFRs) are expressed in most cell populations in the kidney (Orr-Urtreger et al. 1991; Stark et al. 1991).
Another gene likely to have a role in maintaining the
nephrogenic mesenchyme is bone morphogenetic protein-7 (Bmp7). Expression of Bmp7 in the mesenchyme is
initiated when the ureter contacts the metanephric blastema and is maintained in the mesenchyme throughout
kidney development (Dudley et al. 1995; Lyons et al.
1995; Dudley and Robertson 1997; Godin et al. 1998). A
loss-of-function mutation in Bmp7 does not affect the
initial inductive interactions between the ureter and
metanephric blastema (Dudley et al. 1995; Luo et al.
1995). Approximately 48 hr after the first induction,
however, a progressive cessation of nephrogenesis is observed. The onset of the phenotype is coincident with
observed apoptosis in the cortical region (Luo et al. 1995;
Dudley and Robertson 1997). By 16.5 dpc, the mutant
kidneys are small, lack condensed mesenchyme, and
contain many cystic structures. Together, these data
suggest that BMP7 signaling is required for the survival
of metanephric mesenchyme in vivo.
The studies presented here provide new insights into
the role of Bmp7 in the maintenance of nephrogenic
mesenchyme. We show that purified recombinant human BMP7 can promote the survival of mesenchyme
cells in the absence of the ureter. Unlike in cultures
containing freshly isolated metanephric mesenchyme,
however, treated mesenchyme does not undergo tubulogenesis when co-cultured with spinal cord. In contrast,
mesenchyme treated with FGF2 displays a weak tubulogenic response to signals from spinal cord. In combination, BMP7 signaling potentiates the response of mesenchyme to FGF signaling, enabling the formation of many
tubules in cultured mesenchyme following addition of
spinal cord. These data suggest that synergy between
FGF2 and BMP7 signaling maintains the nephrogenic
mesenchyme cell population. In addition, signaling
through these two pathways can repress differentiation of mesenchyme in whole kidney cultures in a
reversible manner, an effect that correlates with expansion of the stromal progenitor cell population. Collectively, these data suggest that signaling within the nephrogenic mesenchyme and between the nephrogenic mesenchyme and stromal progenitor cell population is
necessary for maintenance of nephrogenic mesenchyme
at the tips of the branching ureter during kidney development.
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Results
Bmp7 promotes survival but not differentiation
of metanephric mesenchyme
Previous analysis of null mutants demonstrated that loss
of Bmp7 function results in the progressive cessation of
nephrogenesis, which is correlated with the appearance
of apoptotic cells in the nephrogenic zone (Dudley et al.
1995; Luo et al. 1995). In vivo, mutant kidneys develop
fewer nephrons than wild-type, however the nephrons
that form are functional. These data suggest that Bmp7
function has a role in survival of metanephric mesenchyme but does not affect its ability to undergo tubulogenesis. This interpretation is in contrast to that presented by Vukicevic et al. (1996). These authors demonstrated that mesenchyme explant cultures treated with
50 ng/ml BMP7 express the transcription factor Pax2
and the extracellular matrix molecule laminin A chain,
markers of induced mesenchyme and renal epithelium.
These data suggest that BMP7 signaling is necessary and
sufficient for induction of metanephric mesenchyme. In
our attempts to replicate their results, however, we did
not observe induction of mesenchyme adjacent to BMP7coated beads (Godin et al. 1998).
To address these differences we re-examined the effect
of recombinant BMP7 on isolated metanephric mesenchyme in vitro. As per Vukicevic et al. (1996), BMP7 was
added directly to the culture medium. Explants were cultured for 24–96 hr with medium changes daily or every
other day. Some of the experiments were performed under serum-free conditions, although the data presented
here were derived from cultures exposed to 10% fetal
bovine serum (FBS). Results were essentially the same
regardless of variations in culture conditions. After 48 hr
in culture, control explants treated with bovine serum
albumin (BSA) displayed significant degeneration (data
not shown). Co-culture with spinal cord resulted in induction of mesenchyme and subsequent tubulogenesis
(Fig. 1A) as demonstrated by strong expression of the
transcription factor Pax2 and the secreted signaling molecule Wnt4 (Fig. 1C,E; Dressler et al. 1990; Stark et al.
1994). In contrast, 50 ng/ml BMP7 promotes survival but
not aggregation of the mesenchyme cells (Fig. 1B) or expression of Pax2 and Wnt4 (Fig. 1D,F). Therefore, BMP7
cannot mimic the growth and differentiation effects of
spinal cord on metanephric mesenchyme. Similar results
were obtained in explants cultured for 48–96 hr in the
presence of 10–1000 ng/ml of BMP7. In addition, we
tested whether Bmp7 function was required for induction of mesenchyme. Embryos from Bmp7lacZ heterozygous intercrosses were obtained at 11.5 dpc. Spinal cord
derived from wild-type mice and metanephric mesenchyme isolated from these Bmp7lacZ embryos were recombined and grown under serum-free conditions for 72
hr. Wild-type or heterozygous mesenchyme underwent
tubulogenesis when recombined with like spinal cord
(Fig. 1G). Similarly, Bmp7 mutant spinal cord can promote tubulogenesis in Bmp7 mutant mesenchyme (Fig.
1H). In contrast to wild-type cultures, mutant mesenchyme explants remained small and appeared to contain
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beads. Previous data described a role for FGF2 as a survival factor for metanephric mesenchyme (Perantoni et
al. 1995a; Godin et al. 1998). In these cultures we find an
overall reduction of TOPRO-1 staining throughout the
mesenchyme explant consistent with FGF2 acting as a
potent survival factor (Fig. 2E,F). Interestingly, FGF2treated cultures appear as more coherent cell masses
than control or BMP7-treated explants. The limited region of surviving cells surrounding BMP7-coated beads
may be attributable to differences in protein release from
heparin–Sepharose (FGF2) and Affi-gel blue (BMP7) beads
or may be indicative of short-range signaling by BMP7.
Isolated mesenchyme incubated in medium containing
BMP7 with daily medium changes, however, also did not
survive as well as FGF2-treated cultures (data not
shown). Collectively, these data demonstrate that although both FGF2 and BMP7 signaling can rescue metanephric mesenchyme from cell death, FGF2 may block
apoptosis more effectively. To determine which cell
populations are rescued from apoptosis through either
Figure 1. BMP7 signaling does not induce nephrogenic mesenchyme. Mesenchyme was isolated from 11.5-dpc embryos and
grown in culture for 48 hr in the presence of spinal cord (A,C,E)
or recombinant BMP7 protein (B,D,F). After culture, explants
were sectioned and processed for in situ hybridization. (A,B)
Bright-field and (C–F) dark-field exposures of serial sections. In
the presence of spinal cord the mesenchyme condenses, forms
immature epithelium, and displays strong expression of Pax2
(C) and Wnt4 (E). In contrast, mesenchyme grown in the presence of BMP7 remains loose and does not express Pax2 (D) or
Wnt4 (F). The asterisk in panels B,D, and F indicate an artifact.
Recombinant cultures of wild-type spinal cord and Bmp7lacZ /+
mesenchyme display many LacZ+ early tubules (white arrow) as
well as nonstaining, more mature tubules (G; black arrow). Cultures of Bmp7 mutant mesenchyme isolated from Bmp7lacZ embryos recombined with mutant spinal cord also display well
formed tubules (H).

fewer tubules. Therefore, mutant tissue in recombinant
culture develops similar to mutant tissue in vivo (Dudley et al. 1995; Luo et al. 1995). Together, these data
demonstrate that BMP7 signaling is neither sufficient
nor required for induction of nephrogenic mesenchyme
or subsequent tubulogenesis.
Although BMP7 does not promote differentiation of
the mesenchyme, it appeared from these studies and Godin et al. (1998) that BMP signaling prevents cell death in
mesenchyme explants. To directly test this possibility,
explants were cultured in the presence of a bead coated
with BSA or BMP7 for 48 hr then incubated in medium
containing TOPRO-1, a fluorescent vital dye. As shown
previously, a translucent zone appears in the mesenchyme adjacent to beads soaked in BMP7 but not BSA
(Fig. 2A,C; Godin et al. 1998). Here we demonstrate that
apoptotic cells are distributed uniformly in control explants whereas fluorescent label is restricted from cells
adjacent to BMP7-coated beads (Fig. 2B,D). We compared
survival of mesenchyme treated with BMP7-coated
beads to that of mesenchyme treated with FGF2-coated

Figure 2. BMP7 promotes survival of the nephrogenic mesenchyme. Mesenchyme was isolated from 11.5-dpc embryos and
grown in culture for 48 hr in the presence of a bead containing
BSA (A,B), BMP7 (C,D), or FGF2 (E,F). Explants treated with
BSA appear granular and refractory to light. In contrast, there is
a well organized, translucent region of mesenchyme in the vicinity of the BMP7-soaked bead (cf. cells indicated by arrow in
A and C). Staining with the vital dye TOPRO-1 reveals that cells
in the BSA-treated mesenchyme are dying as indicated by fluorescent signal (B), whereas, in the BMP7-treated mesenchyme,
cells in the translucent region do not fluoresce, indicating that
these cells are viable (cf. cells indicated by arrow in B and D).
Interestingly, most of the cells in the explant survive when
treated with FGF2 (E,F). Note that the heparin–Sepharose beads
in E and F display autofluorescence. (b) Bead. Scale bar, 100µm.
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BMP7 or FGF2 signaling, we performed whole-mount in
situ hybridization on explants cultured with beads (data
not shown). In brief, control and treated cultures displayed uniform, low-level expression of WT1, a marker
of nephrogenic mesenchyme cells; BF2, a winged-helix
transcription factor expressed exclusively by stromal
progenitor cells; and lacked expression of Pax2. These
data suggest that the surviving cell population is comprised of a mixture of stromal progenitor cells and uninduced nephrogenic mesenchyme cells.
Bmp7 and FGF2 signaling function synergistically
in metanephric mesenchyme
One caveat to mesenchyme explant experiments is that
added factors must first promote survival of the mesenchyme if any effect of the factors on differentiation is to
be ascertained. Because BMP7 does not provide robust
protection from apoptosis, we concluded that previous
experiments using isolated metanephric mesenchyme
were unlikely to reveal the function of Bmp7. To overcome this problem, we tested the activity of BMP7 in
combination with FGF2. For our experiments, mesenchyme was obtained from Bmp7lacZ heterozygous embryos so that induced mesenchyme and the resultant tubules could be identified readily by LacZ activity (Godin
et al. 1998). Mesenchyme was cultured in the presence of
factors for 48–96 hr with medium changes daily. Following incubation, cultures were fixed and stained for LacZ
activity. Explants cultured in medium without additional factors degenerated (data not shown). Cultures
treated with 50 ng/ml BMP7 remained small and degenerated slowly (Fig. 3A). A few scattered LacZ+ cells are
occasionally detected in these cultures. As reported previously, FGF2 treatment promoted growth and survival
of the culture (Fig. 3B). Many LacZ+ cells were present in
these cultures, however, these cells did not form aggregates as observed in induced mesenchyme (Fig. 1G; Godin et al. 1998). Explants treated with both BMP7 and
FGF2 were consistently larger than explants cultured
with FGF2 alone, and they rarely contain LacZ+ cells
(Fig. 3C). The absence of significant LacZ activity in
these cultures suggests that none of these treatments
promotes induction of the mesenchyme (Godin et al.
1998). Accordingly, neither Pax2 nor Wnt4 transcripts
were detected in these cultures (Fig. 3E,F,H,I) but were
readily detected in mesenchyme explants co-cultured
with spinal cord (Fig. 1C,E). Therefore, BMP7 signaling
promotes growth but not differentiation of the mesenchyme in the presence of FGF2 signaling.
Because Bmp7, a marker of induced metanephric mesenchyme, was expressed in explants treated with FGF2
but not those exposed to both FGF2 and BMP7, we
wanted to test whether nephrogenic mesenchyme cells
were also present in these cultures. Therefore, we tested
whether treated mesenchymes could form nephrons in
response to signaling by spinal cord. Metanephric mesenchyme was cultured for 48 hr as described above. Explants were then transferred to medium lacking these
factors and two pieces of freshly dissected spinal cord
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Figure 3. BMP7 and FGF2 function synergistically to promote
survival and growth of mesenchyme explants. Mesenchyme
was isolated from 11.5-dpc Bmp7lacZ /+ embryos and grown in
culture for 48 hr in the presence of BMP7 (A), FGF2 (B,D–F), or
both BMP7 and FGF2 (C,G–I). After culture, explants were
stained in X-gal or fixed and processed for in situ hybridization.
Mesenchyme treated with BMP7 displays limited survival.
FGF2 promotes better survival of the mesenchyme. Treatment
with both factors results in survival and growth of the isolated
mesenchyme. Interestingly, these cultures display translucent
regions (C, arrow) similar to that observed around BMP7- or
FGF2-soaked beads. Marker analysis reveals LacZ+ cells in cultures treated with FGF2 (B, arrow). In addition, neither FGF2
(D–F) or FGF2 + BMP7-(G–I) treated cultures express Pax2 or
Wnt4, demonstrating that induction has not occurred in these
explants.

were placed in contact with the mesenchyme. After an
additional 48-hr incubation, cultures were fixed and
stained for LacZ activity. In the absence of added factors,
control cultures degenerated during the experiment and
did not respond to signals from spinal cord (data not
shown). Explants pre-incubated in the presence of 100
ng/ml of FGF2 displayed many single LacZ+ mesenchymal cells and a few small aggregates following induction
by spinal cord (Fig. 4A). Similarly, mesenchyme pretreated with 50 ng/ml BMP7 responded only weakly to
inductive signals (Fig. 4B). The combination of 50 ng/ml
of BMP7 and 100 ng/ml of FGF2, however, resulted in a
robust response to spinal cord so that tubule formation
was clearly observed (Fig. 4C, E) and was qualitatively
similar to freshly isolated mesenchyme co-cultured with
spinal cord for 48 hr (Fig. 4D,F). Increased doses of BMP7
or FGF2 did not appreciably alter the response of mesenchyme to spinal cord (data not shown). The above experiment was also performed using lithium rather than
spinal cord as an inducer of nephrogenic mesenchyme
(Davies and Garrod 1995; Godin et al. 1998; data not
shown). In these experiments, pretreatment of the mesenchyme with both FGF2 and BMP7 resulted in large
regions of the lithium-induced explant displaying LacZ
activity, whereas FGF2 alone yielded only a few LacZ+
cells and BMP7-treated explants were mostly negative.
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Figure 4. BMP7 and FGF2 signaling maintain nephrogenic
mesenchyme in vitro. Mesenchyme was isolated from 11.5-dpc
Bmp7 lacZ /+ embryos and grown in culture for 48 hr in the
presence of recombinant FGF2 (A), BMP7 (B), or both (C). Mesenchyme was then placed in contact with spinal cord and grown
for an additional 48 hr. As a control, freshly isolated mesenchyme was placed immediately in contact with spinal cord (D).
After culture, explants were stained in X-gal. Neither FGF2 nor
BMP7 alone maintain a population of cells competent to undergo induction, though a few LacZ+ cells and small aggregates
of cells are often seen in these cultures (black arrows). In contrast, pretreatment with both factors allows a robust response of
the explant to induction (white arrows). Sections through
FGF2 + BMP7 (E) and control (F) cultures demonstrate that
stained regions contain tubules and forming glomeruli (black
arrows) as well as more mature, nonstaining tubules (white arrows). In addition, regions of stained, nonaggregated cells are
readily observed in cultures pretreated with FGF2 + BMP7.

As expected, tubules did not form in these cultures as
lithium can only mimic the initial inductive event (Davies and Garrod 1995; Godin et al. 1998). These data
strongly suggest that BMP7 signaling potentiates the activity of FGF2, resulting in the maintenance of nephrogenic mesenchyme cells capable of responding to inductive signals.
BMP7 and FGF2 signaling oppose tubulogenesis
To address whether BMP7 and FGF2 act synergistically
to maintain a population of nephrogenic mesenchyme in
the context of a developing kidney, we examined the
effect of these factors on whole organ cultures. Metanephric rudiments from 11.5-dpc embryos derived from
heterozygous intercrosses were cultured on Nuclepore
membrane rafts in medium containing 10% FBS. After
48–96 hr in culture, the rudiments were fixed in 100%
methanol. To visualize ureteric branching and nephron
formation, explant cultures were immunostained for

laminin, a basement membrane protein in epithelial tissues. Under these culture conditions, the ureter in wildtype kidneys branches several times and many nephrons
are formed (Fig. 5A). In contrast, the ureter in mutant
kidneys branches less and the resultant explant is significantly smaller than that from wild-type littermates
(Fig. 5B). In addition, mutant explants are packed with
large, abnormally shaped nephrons (Fig. 5, cf. D and E).
This is surprising because we predicted that apoptosis of
nephrogenic mesenchyme cells in mutant kidneys
would result in the absence of tubules at the termini of
the ureteric branches. Instead, this observation suggests
that in the absence of BMP7 signaling, the nephrogenic
mesenchyme also undergoes premature differentiation.
To test whether BMP7 activity can antagonize signals
promoting tubulogenesis, we cultured wild-type kidneys
in the presence of BMP7, FGF2, or both for 48 hr and
then determined the extent of tubulogenesis following
staining for laminin. After 48 hr, nephrons are found
adjacent to most of the termini of the ureteric branches
(Fig. 5A,D). In kidneys treated with 50 ng/ml BMP7, the
ureter branches normally and many tubules are observed
(Fig. 5C). Unlike the situation in control explants, however, a significant portion of the ureteric termini remained surrounded by condensed mesenchyme and lack
mature nephrons (Fig. 5F). At higher doses, BMP7 can
significantly inhibit tubulogenesis (data not shown).
Likewise, 100 ng/ml FGF2 decreases formation of nephrons in the periphery (Fig. 5G,J). In combination, these
two molecules strongly inhibit nephrogenesis, resulting
in the majority of ureteric tips lacking nephrons (Fig.
5H,K). To determine whether the inhibition of nephrogenesis is caused by an adverse effect of this treatment
regimen on the peripheral mesenchyme population,
some kidney explants were transferred to medium without added factors following the initial culture period and
incubated for an additional 48 hr. In most cases, removal
of BMP7 and FGF2 from the medium permitted tubulogenesis to resume in the periphery, resulting in nephrons
adjacent to the tips of the ureter (Fig. 5, cf. H and K with
I and L). Additionally, in some treated explants the peripheral mesenchyme population was labeled with the
fluorescent lineage tracing dye DiI. Following transfer of
the explants to medium without added factors, DiI-labeled cells were incorporated mainly into the stromal
cells surrounding the nephrons, further demonstrating
that these cells remain viable and functional following
treatment with BMP7 and FGF2 (data not shown). The
ability of BMP7 signaling to inhibit nephron formation
was corroborated using a second assay. Mesenchyme explants containing a bead soaked in BSA or BMP7-containing media were co-cultured with spinal cord for 24–
48 hr. Following serial sectioning, nephrogenesis was
analyzed in these cultures both histologically and by expression of Pax2 and Wnt4. Condensed mesenchyme and
immature tubules were often detected adjacent to beads
soaked in BSA but rarely within 100-150 µm of BMP7coated beads (data not shown). Collectively, these data
provide strong evidence that BMP7 activity can repress
nephrogenesis in induced metanephric mesenchyme.
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Figure 5. BMP7 and FGF2 signaling oppose
tubulogenesis. Whole kidneys were isolated
at 11.5-dpc and grown on Nuclepore filter
rafts. After culture, explants were stained
with an anti-laminin antibody via indirect immunofluorescence. Low magnification (A–C,
G–I) and high magnification (D–F, J–L) views
of explants are presented. (A,D) Kidney explant grown for 48 hr in the presence of 10%
FBS. (B,E) Bmp7 mutant kidney grown for 48
hr in the presence of 10% FBS. Arrows in D and
E indicate nephrons that have formed in the
periphery. Note how mutant tubules appear
larger and less organized than wild-type. Wildtype kidneys grown in the presence of recombinant BMP7 (C,F), FGF2 (G,J), or both factors
(H,K). BMP7 seems to have little effect on the
branching of the ureter, however, tips of the
ureter are often found free of nephrons (F, arrow). FGF2 signaling alone or in combination
with BMP7 also reduces nephron formation in
the periphery of the explant (arrows in J and
K). In contrast to kidneys treated with BMP7
alone, however, FGF2 signaling causes a rind
of cells to form in the periphery of the explant
(G, arrow). In combination, both factors promote an even greater expansion of this outer
cell population (H, arrow). Explants treated
with FGF2 + BMP7 for 48 hr, subsequently
placed in fresh culture media lacking these
factors and grown for an additional 48 hr, display extensive tubulogenesis in the periphery
of the kidney (I,L).

Interestingly, in addition to preventing tubulogenesis,
BMP7 and FGF2 together promote overgrowth of a peripheral mesenchyme cell population (Fig. 5, cf. A, C,
and G with H). This region contains at least two cell
types—the nephrogenic mesenchyme, precursor cells of
nephrons, and progenitor cells of the kidney stroma. Results from DiI labeling (described above) suggest that the
expanded cell population is composed predominantly of
stromal progenitor cells. To determine which cell populations is affected by treatment with these factors, we
examined the expression of marker genes by wholemount in situ hybridization following explant culture.
Nephrogenic mesenchyme cells were identified by expression of the transcription factors WT1 and Pax2, and
the secreted signaling molecule Bmp7. Pax2 and Bmp7
are also expressed strongly in the ureteric epithelium. In
control kidney cultures, expression of these markers is
observed in mesenchyme cells adjacent to the tips of the
ureter (Fig. 6A,C,E). Similar expression patterns are observed in kidneys exposed to both BMP7 and FGF2 (Fig.
6B,D,F). Interestingly, none of these markers are expressed in the peripheral mesenchyme in treated kidneys. In contrast, the more peripheral population of mesenchyme was positive for expression of BF2, a wingedhelix transcription factor that marks the stromal
progenitor cell population (Fig. 6G,H; Hatini et al. 1996).
Sections through these explants localize BF2 expression
to the peripheral stromal progenitor cell population (Fig.
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6I,J). Therefore, together, BMP7 and FGF signaling promote expansion of the stromal progenitor cell population
while repressing differentiation of the adjacent nephrogenic mesenchyme.
FGFRs are expressed in the nephrogenic region
Because exogenous sources of BMP7 and FGF2 activity
have strong effects on the metanephric mesenchyme-cell
populations in explant and whole kidney cultures, we
next asked whether the spatial and temporal expression
patterns of the relevant genes are consistent with their
proposed roles. We and others have demonstrated by
both in situ hybridization and analysis of embryos carrying the Bmp7lacZ allele that Bmp7 is expressed in both
the ureteric epithelium and the adjacent condensed mesenchyme, but not in the surrounding stromal progenitor
cells (Dudley et al. 1995; Lyons et al. 1995; Dudley and
Robertson 1997; Godin et al. 1998). It has been shown
that Fgf2 is expressed in the ureter of the rat (Perantoni
et al. 1991; Perantoni et al. 1995a,b; Cancilla et al. 1996).
We have been unable to confirm this expression pattern
in the mouse by in situ hybridization but have demonstrated expression of Fgf2 in kidneys from 12.5-dpc embryos by RT–PCR (data not shown). It is unlikely, however, that FGF2 is the relevant signal as Fgf2 null mutant
mice do not display kidney defects (Zhou et al. 1998).
Rather than examine the expression patterns of all 18
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(Fig. 6)—it is likely that Fgfr1 is expressed by stromal
progenitor cells but not by condensed mesenchyme. It
appears, however, that Fgfr1 may be expressed in only a
subpopulation of stromal progenitor cells because expression is detected only at the periphery of the explant,
not in the BF2-positive cells adjacent to the condensed
mesenchyme. In contrast, in both untreated and treated
whole kidney cultures, Fgfr2 is expressed in the ureter
and condensed mesenchyme but not in the stromal
progenitor cell population (Fig. 7C,D). Therefore, it appears that the nephrogenic mesenchyme and stromal
progenitor cells use different receptors to transduce FGF
signals.

Discussion

Figure 6. BMP7 and FGF2 promote expansion of the stromal
progenitor cell population. Whole kidneys were isolated at 11.5
dpc and grown for 48 hr in culture containing 10% FBS in the
absence (A,C,E,G,I) or in the presence of both BMP7 and FGF2
(B,D,F,H,J). After culture, explants were processed for wholemount in situ hybridization or stained in X-gal. (A) Pax2 is
expressed in the ureter and in the condensed mesenchyme. (B) A
similar expression pattern is observed in the treated kidneys.
WT1 is expressed in the condensed mesenchyme associated
with the tips of the branching ureter in both control (C) and
treated kidneys (D). X-gal staining for the Bmp7lacZ allele also
shows a similar expression pattern in both the control (E) and
treated (F) explants. In all cases the expanded rind of cells in the
periphery of the kidney do not express any of these markers of
induced mesenchyme (arrow). The stromal precursor marker
BF2 (G), however, is expressed in this expanded population of
cells (H). Sections through G and H reveal that BF2 is expressed
throughout the expanded region of mesenchyme cells (arrow,
I,J). The apparent BF2 signal in the nephrogenic mesenchyme is
attributable to the layer of stromal progenitor cells that encompasses the entire explant (G,H).

members of the FGF family, we decided to focus on the
expression of the two FGFRs, expressed in mesenchyme
populations in the developing kidney (Orr-Urtreger et al.
1991). As described previously, Fgfr1 is expressed in the
mesenchyme but not in the ureter of wild-type kidneys
(Fig. 7A). Surprisingly, in cultured kidneys treated with
BMP7 and FGF2, Fgfr1 expression is detected only in a
peripheral rind of mesenchyme (Fig. 7B). As this cell
population expresses BF2—but not WT1, Bmp7, or Pax2

Previous studies demonstrated that BMP7 signaling is
required for development of the murine kidney (Dudley
et al. 1995; Luo et al. 1995). These reports suggested that
BMP7 produced by the metanephric mesenchyme promotes cell survival via an autocrine pathway. There is an
important caveat to this interpretation. Survival and differentiation of the metanephric mesenchyme is dependent on interaction with the ureter. Therefore a decrease
in growth or function in a Bmp7-deficient ureter could
adversely affect survival of the mesenchyme. To overcome this problem, we employed two experimental approaches. First, we analyzed the effect of recombinant
BMP7 on isolated metanephric mesenchyme cultured in
the absence of ureteric epithelium. Second, we examined
the effect of BMP7 on spinal cord induced differentiation
of mesenchyme. Using these methods and others we

Figure 7. FGFR expression in BMP7/FGF2-treated kidney explants. Whole kidneys were isolated at 11.5 dpc and grown for
48 hr in culture in 10% FBS (A,C) or in the presence of BMP7
and FGF2 (B,D). After culture, explants were processed for
whole-mount in situ hybridization. Fgfr1 is expressed in the
most peripheral mesenchyme of both control (A) and treated (B)
explants. Fgfr2 is expressed in the ureteric tissue as well as in
the condensed mesenchyme of both control (C) and treated (D)
explants but is absent from the peripheral mesenchyme. (long
arrow) Stromal cells; (short arrow) condensed nephrogenic mesenchyme.
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demonstrate that synergy between BMP7 and FGF2 signal transduction regulates several key processes during
nephrogenesis.

BMP7 and FGF2 are not inducers
of metanephric mesenchyme
Analysis of null mutations in Bmp7 by two groups resulted in controversy over whether BMP7 signaling mediates induction of metanephric mesenchyme (Luo et al.
1995) or acts to promote survival of the nephrogenic
mesenchyme (Dudley et al. 1995; Dudley and Robertson
1997). Using in vitro methods, Vukecevic et al. (1996)
provided support for a role of BMP7 in induction of mesenchyme. These investigators demonstrated that explants of metanephric mesenchyme express the epithelial cell markers Pax2 and laminin A chain when cultured for 48 hr in the presence of 50 ng/ml BMP7.
Despite numerous attempts, we were unable to replicate
these data. Under a variety of culture conditions, doses
of BMP7 ranging from 10–1000 ng/ml did not result in
the formation of condensates or the expression of Pax2
and Wnt4 in cultures of isolated mesenchyme. These
data demonstrate that BMP7 signaling alone is not sufficient to promote induction of mesenchyme explants
but these experiments do not rule out a role for Bmp7 in
the process of induction. In support of a role for BMP7
signaling in induction of metanephric mesenchyme, previous experiments demonstrated that antisense oligonucleotides directed against Bmp7 transcripts inhibit
spinal cord-induced differentiation of mesenchyme (Vukicevic et al. 1996). Here we show that Bmp7 mutant
mesenchyme can be induced by mutant spinal cord in
serum-free culture, making it likely that the inhibition
of tubulogenesis observed in the previous study is not
attributable specifically to loss of BMP7 production in
either the mesenchyme or spinal cord. These data, combined with our previous results (Dudley et al. 1995; Godin et al. 1998), conclusively demonstrate that BMP7
signaling is neither sufficient nor required for induction
of metanephric mesenchyme.
In addition, we find no evidence to support the notion
that FGF2 signaling mediates early inductive events in
explants of mouse metanephric mesenchyme, as suggested for the rat (Perantoni et al. 1995a). We detect
weak expression of some markers of induction (i.e. Bmp7
and WT1) following treatment of isolated mesenchyme
with FGF2, but the level of expression is generally well
below that of mesenchyme induced by spinal cord or
lithium chloride (this report; Godin et al. 1998). Although these low levels of expression might represent a
weak inductive response, the fact that these markers
can be detected in untreated cultures up to 24 hr after
explanting (A.T. Dudley and R.E. Godin, unpubl.) suggests that FGF2 signaling acts to maintain cells in an
induced state in the absence of continuous inductive signals.
If explants treated with BMP7 or FGF2 are not induced, how do we account for the presence of LacZ+ cells
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in similarly treated cultures (Fig. 3; Godin et al. 1998)?
Perdurance of LacZ activity in the absence of continued
gene expression is unlikely as LacZ+ cells are not detected in mesenchyme cultured for the same amount of
time in the presence of both FGF2 and BMP7. In addition, we demonstrated previously that LacZ activity is
rapidly lost in maturing tubules (Godin et al. 1998). Our
previous results suggest that Bmp7 is an early marker of
induced nephrogenic mesenchyme cells that is expressed
before or independently of Pax2 and Wnt4 (Godin et al.
1998). Therefore, we suggest that Bmp7 expression
marks one of the earliest stages of induction of nephrogenic mesenchyme cells. Because they can exist as
single, LacZ+ mesenchymal cells in these explants (Fig. 3
and 4), it is likely that the phenotype is maintained, in
part, through autocrine signaling that is not BMP7-dependent (Godin et al. 1998). FGF2 signaling promotes
survival of these cells and, in addition, may help maintain this phenotype. On the other hand, BMP7 signaling
alone or in combination with FGF2 signaling greatly reduces or eliminates LacZ+ cells in these cultures (Fig. 3).
It is unlikely that these cells die or change fate, as tubules form following induction by spinal cord in cultures
of mesenchyme pretreated with BMP7 and FGF2 (Fig. 4).
One possible explanation for this observation is that
BMP7 signaling negatively regulates Bmp7 transcription
either directly or through the inhibition of another signaling pathway. Alternatively, increased BMP7 signaling
may force cells into an earlier developmental state characterized by the absence of expression of any currently
known gene associated with induction.
Synergy between BMP7 and FGF2 signaling
regulates nephrogenesis
The data presented here demonstrate three roles for
BMP7 signaling during development of the metanephros.
First, they demonstrate that BMP7 activity can preserve
nephrogenic mesenchyme cells in vitro in the absence of
continuous induction. The mechanism underlying the
maintenance of this cell population may include the prevention of cell death, the stimulation of cell proliferation, or the preservation of competence to respond to
inducing factors. The data presented here (Fig. 2), in combination with our previous results (Godin et al. 1998),
provide conclusive evidence that BMP7 signaling promotes survival of mesenchyme cells. In addition, we
demonstrate that FGF2 prevents apoptosis of metanephric mesenchyme isolated from the mouse as shown previously for the rat (Perantoni et al. 1991; Perantoni et al.
1995a). One interesting question is why, if both BMP7
and FGF2 signaling prevent apoptosis in mesenchyme
explants (Fig. 2), can only explants treated with FGF2 be
induced (Fig. 4)? There are several possible explanations.
FGF2 signaling may be more effective for promoting survival of nephrogenic mesenchyme cells as suggested in
Figure 2. Alternatively, FGF2 may promote proliferation
of the nephrogenic stem cells in addition to ensuring
their survival. In this case, FGF2 signaling might increase the number of nephrogenic mesenchyme cells

Downloaded from genesdev.cshlp.org on January 6, 2015 - Published by Cold Spring Harbor Laboratory Press

BMP and FGF signaling in kidney development

past a critical level necessary for tubulogenesis. This
nonlinear relationship between cell number and biological effect has been termed the ‘community effect’ (Gurdon 1988). Moreover, previous studies suggest that cell
mass may be a critical factor during nephron formation
(Gossens and Unsworth 1972). In addition, it is possible
that FGF2, but not BMP7, regulates competence of nephrogenic mesenchyme cells to respond to inducing signals. This possibility is consistent with the observation
that induced, LacZ+ cells are rarely detected following
induction by spinal cord in explants treated with BMP7
alone but are readily observed in cultures treated with
FGF2 (Fig. 4). Finally, BMP7 signaling alone may alter
the fate of nephrogenic mesenchyme cells. It has been
suggested that nephrogenic mesenchyme cells and stromal progenitor cells are derived from a common progenitor cell. Perhaps BMP7 signaling directs cells to the stromal cell lineage in the absence of FGF signaling. A role
for BMP signaling in cell fate determination has been
described in cultures of neural crest cells (Varley et al.
1995; Shah et al. 1996). In order to examine the above
possibilities, it is important to be able to distinguish
cells derived from the nephrogenic mesenchyme from
those of the stromal lineage in explant culture in the
absence of induction. Unfortunately, all markers described to date for the nephrogenic mesenchyme are dependent on inductive signals.
A second, unexpected, role for BMP7 was revealed by
these studies. In whole kidney culture, Bmp7 mutant
kidneys undergo extensive tubulogenesis. This is not the
predicted result if BMP7 acts primarily to suppress apoptosis in the nephrogenic mesenchyme (Luo et al. 1995;
Dudley and Robertson 1997). Interestingly, treatment of
whole kidneys with BMP7 results in a decrease in tubulogenesis in the periphery of the explant. Similarly, mesenchyme adjacent to a BMP7-soaked bead does not express markers of induction following coculture with spinal cord. Collectively, these data demonstrate that
BMP7 activity is one component of a pathway controlling the rate of nephrogenesis by repressing tubulogenesis. One possible mechanism to account for the inhibition of tubulogenesis is the down-regulation of genes required for response of the mesenchyme to inductive
signals. Currently little is known about the pathway
downstream of the inductive signals. Only one gene
product, the transcription factor WT1, has been shown
to be required cell autonomously for induction of the
mesenchyme (Kreidberg et al. 1993). Consistent with
this mode of action, our analysis revealed a decrease
in expression of WT1 in kidneys treated with BMP7
and FGF2 versus untreated controls (Fig. 6). Further
analysis will determine whether this is attributable to
changes in the expression level in individual cells or a
decrease in the absolute number of expressing cells.
Similarly, BMP7 signaling can suppress expression of
Bmp7lacZ, a marker of induced mesenchyme, in explants
treated with FGF2 (Fig. 3). Finally, we demonstrate that
BMP7 signaling promotes expansion of the stromal progenitor cell population. Implications of this finding are
discussed below.

One element common in each of these processes is
that BMP7 signaling potentiates the effect of FGF signaling. For example, following pretreatment with both
BMP7 and FGF2, explants of metanephric mesenchyme
respond more strongly to signals from the spinal cord
than cultures treated with FGF2 alone (Fig. 4). These
data provide the first demonstration of synergy between
BMP and FGF signaling pathways during metanephric
development. Similar interactions between the BMP and
FGF signaling pathways have also been described in the
specification of pre-cardiac mesoderm (Lough et al.
1996). These findings are intriguing because in many
other systems, FGF and BMP signaling act antagonistically (Niswander and Martin 1993; Neubuser et al. 1997;
Wappner et al. 1997; Ericson et al. 1998; Kretzschmar
and Massagué 1998). Such disparate results are not unexpected, however, as both the FGF and TGFb/BMP signal transduction pathways are highly complex and sensitive to both extracellular and intracellular environments. Based on current understanding of the FGF and
BMP signal transduction pathways, we cannot propose a
mechanism governing the interactions we observe in the
kidney. In part, this is because of a lack of information
concerning the expression of FGF family members in the
kidney. Recently, the first defect in kidney development
caused by a mutation in an FGF family member (Fgf7)
was reported (Qiao et al. 1999). Expression, however, of
Fgf7 exclusively in the mature stroma and the limited
disruption of nephrogenesis as a result of the mutation
suggest that FGF7 signaling does not mediate the events
described here. In contrast, BMP7 is expressed in both
the ureter and the nephrogenic mesenchyme (Lyons et
al. 1995; Dudley and Robertson 1997). In addition, BMP7
is the only BMP family member identified to date that is
expressed in the nephrogenic mesenchyme, whereas expression of BMP family members in the stromal progenitor cells has not been described (Lyons et al. 1995; Dudley and Robertson 1997). As it appears to act as a shortrange signal (Fig. 2; Vukicevic et al. 1994), BMP7
produced by the nephrogenic mesenchyme is likely to
mediate effects on both cell populations in vivo.
Interactions between stromal progenitor cells
and metanephric mesenchyme
The observation that BMP7 and FGF signaling together
result in growth of the stromal progenitor cell population has important implications for tissue interactions
during nephrogenesis. The current model of nephrogenesis involves two sets of interactions between three cell
populations. First, reciprocal interactions between the
ureter and mesenchyme promote growth and branching
of the ureter, as well as survival and differentiation of the
mesenchyme. Second, the stromal progenitor cells and/
or mature stromal cells signal to the nephrogenic mesenchyme to control nephrogenesis. The latter interaction was first revealed by a disruption of kidney morphogenesis using antibodies directed against GD3 (Sariola et
al. 1988), a cell-surface molecule expressed on stromal
cells, and later elaborated on through analysis of BF2
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(Hatini et al. 1996) and, more recently, retinoic acid receptor (RAR) mutant embryos (Mendelsohn et al. 1999).
The RAR mutations do not affect nephrogenesis significantly, whereas a loss of BF2 function in stromal progenitor cells resulted in a significant reduction in
nephrogenesis, apparently without altering the size of
the stromal cell population. Here we demonstrate a
novel interaction between the nephrogenic mesenchyme
and the stromal progenitor cells. In whole kidney cultures, expansion of the stromal progenitor cell population by FGF2 is enhanced by BMP7, a ligand produced by
induced nephrogenic mesenchyme (Lyons et al. 1995;
Dudley and Robertson 1997; Godin et al. 1998). Therefore the condensed mesenchyme and stromal progenitor
cells interact reciprocally and not unidirectionally as
suggested previously (Hatini et al. 1996; Mendelsohn et
al. 1999). An important implication of this model is that
development of the stromal progenitor cell and mature
stromal cell populations are controlled throughout kidney development by the induced mesenchyme. These
results extend previous studies demonstrating an influence of induction on establishment of stromal/stromal
progenitor cell populations in cultures of isolated metanephric mesenchyme (Aufderheide et al. 1987). One caveat to our model is that BMP7 can signal through several different receptors (Yamashita et al. 1995), the expression patterns of which have not been analyzed in
detail in the developing kidney. Therefore it is possible
that BMP7 signals only to the nephrogenic mesenchyme
via an autocrine loop and the interaction we describe is
mediated indirectly by BMP7 through an unidentified
molecule. One prediction of this model is that loss of
BMP7 signaling in the kidney would result in a decrease
in stromal progenitor cell formation. In contrast, kidneys from Bmp7 null embryos appear to contain a
normal stromal progenitor cell population by virtue of
BF2 expression (A.T. Dudley, unpubl.). This does not,
however, rule out a role for BMP7 signaling in the development or function of stromal progenitor cells. Because
FGF signaling alone can stimulate growth of the stromal
progenitor cell population (Fig. 5), these data only suggest that BMP7 is not a limiting factor in this process.
An interesting possibility suggested by these data is
that signals from stromal progenitor cells may have an
important role in maintaining a population of nephrogenic mesenchyme at the tips of the branching ureter.
We infer this from several observations. FGF2 signaling
maintains nephrogenic mesenchyme cells in the absence
of spinal cord (Fig. 4) and promotes expansion of the stromal progenitor cell population (Figs. 6 and 7). In contrast,
BMP7 signaling alone neither maintains competent
nephrogenic mesenchyme in culture nor results in
growth of the stromal progenitor cell population in intact kidney explants. Therefore, it is possible that signals
from the stromal progenitor cells help maintain the
nephrogenic mesenchyme cell population (Fig. 4). If this
is correct, the increased response to spinal cord of mesenchyme explants treated with both FGF2 and BMP7
(Fig. 4) may be attributable to an increase in size of (Figs.

1610

GENES & DEVELOPMENT

3 and 6) or signaling by the stromal progenitor cell population. In addition, a correlation between the increase
in size of the stromal progenitor cell population and
decrease in nephron formation in kidney explants
(Fig. 6 and 7) suggests that signals from stromal progenitor cells may also maintain nephrogenic mesenchyme by
antagonizing tubulogenesis. This assertion, however,
contradicts the conclusions of Hatini et al. (1996). Their
analysis of BF2 mutant kidneys suggests that signaling by stromal progenitor cells promotes nephron formation. This paradox can be resolved if BF2 function
does not promote tubulogenesis but is required to negatively regulate a stromal progenitor cell signaling
pathway that antagonizes tubulogenesis. In this case, a
loss of BF2 would result in an increase in signals opposing differentiation. If nephrogenic mesenchyme
cells continue to proliferate without differentiating into
nephrons, the condensates of mesenchyme surrounding the tips of the ureteric branches will expand. Therefore, this model can account for the primary defects observed during development of BF2 mutant kidneys
(Hatini et al. 1996). If this prediction is correct, the decrease in tubulogenesis observed in BF2 mutant kidneys
might be partially compensated for by the increased propensity of Bmp7 mutant mesenchyme to differentiate
(Fig. 5).
In summary, these data suggest several important
modifications to current models of nephrogenesis (Fig.
8). Following contact, reciprocal interactions between
the ureteric epithelium and metanephric blastema result
in the establishment and maintenance of BMP7 production by the nephrogenic mesenchyme cell population.
For the purpose of this model, we presume that nephrogenic mesenchyme cells are the source of BMP7 regulating the processes described here because of the apparent
short-range effects of BMP7 in culture. We do not, however, preclude the possibility that BMP7 produced by
the ureter has an important role. Adjacent to the tips of
the ureter, autocrine BMP7 signaling combined with
signaling through FGFR2 maintains a population of
nephrogenic mesenchyme cells at the tips of the branching ureter by repressing apoptosis and opposing differentiation of the mesenchyme. In addition, paracrine signaling by BMP7 interacts with FGF signaling
through FGFR1 to promote proliferation of the BF2-positive stromal progenitor cells, which in turn provide signals that help maintain the nephrogenic mesenchyme
cell population. Although in our model differentiation
of the nephrogenic mesenchyme is repressed by both
signals from the stromal progenitor cells and by autocrine BMP7 signaling, these two pathways may not function equally in vivo. Exogenously added BMP7 and FGF2
increases signaling in metanephric mesenchyme cell
populations leading to growth of the stromal progenitor
cells and a decrease in tubulogenesis. Based on this
model of nephrogenesis, the defects observed in Bmp7
mutant kidneys may be attributable directly to a failure
of BMP7 signaling in the nephrogenic mesenchyme or,
indirectly, to a loss of signals from the stromal progenitor cells.
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Tissue culture
Explant cultures Animals were sacrificed by asphyxiation
with halothane. Kidneys were isolated from 11.5-dpc embryos
and dissected in L-15 medium supplemented with 1% serum.
To obtain isolated mesenchyme, kidneys were treated with
0.25% trypsin for 6 min on ice, then washed in dissection medium (L-15 medium supplemented with 1% serum). The mesenchyme was teased away from the ureter using 26G needles.
Explants of mesenchyme or whole kidneys were grown at 37°C,
5% CO2 on 0.1µm pore size Nuclepore polycarbonate filters
(Corning) in F12/DMEM 1:1 (GIBCO) supplemented with either
10% defined fetal bovine serum (Hyclone) or 50 µg/ml of human transferrin (GIBCO) and 1% insulin/transferrin/selenium
(Sigma). For transfilter cultures, the spinal cord was cultured
between two 1-µm filters on a Trowell-type screen. Freshly isolated mesenchyme was then placed on top. In some experiments, the medium was supplemented with 100 ng/ml FGF2
(Sigma, catalog no. F-0291). At least three explants per treatment were prepared for each experiment. Experiments were repeated three to six times on different days. Recombinant BMP7
was obtained from Creative Biomolecules (Framingham, MA).
Activity of stock solutions was tested by the method of Ruppert
et al. (1996). Affigel blue beads were prepared as described previously (Godin et al. 1998).

Figure 8. Model of kidney development. This model represents a ureteric bud that has just entered the metanephric mesenchyme and displays the signaling that occurs between the
various cell types of the developing kidney based on data in the
literature and results presented here. During normal development, signals from the ureteric bud (gray) are required for induction of the nephrogenic mesenchyme (blue). In turn, these
cells signal to the adjacent stromal progenitor cells (red) promoting their survival, growth, and differentiation. In a reciprocal manner, the stromal progenitor cells send an antidifferentiation signal to the nephrogenic mesenchyme to control the
rate of nephrogenesis. In addition, these cells may also send a
survival factor to the nephrogenic mesenchyme. Potential molecules involved in these signaling events are listed. In BMP7/
FGF2-treated kidney explants, increased levels of BMP7 and
FGF lead to increased survival of the nephrogenic mesenchyme
as well as to an expansion of the stromal precursor cells. As a
result, there is an increased level of the antidifferentiation signal coming from the stromal precursor cells. Therefore, differentiation of the nephrogenic mesenchyme is reduced. At this
time, the source of the FGF signal is unknown. In Bmp7 mutant
kidneys, lack of BMP7 signaling (white) leads to loss of proper
signaling from the stromal precursor cells (pink), thereby resulting in premature differentiation and perhaps increased cell
death in the nephrogenic mesenchyme.

Materials and methods
Mouse lines
Derivation, maintenance and genotyping of the Bmp7m1Rob and
the Bmp7lacZ mouse lines were described previously (Dudley et
al. 1995; Godin et al. 1998). ICR strain of mice were obtained
from Taconic.

X-gal staining for lacZ activity Kidney explants were fixed in
X-gal buffer (PBS, 5 mM EGTA, 2 mM MgCl?6H2O, 0.2% NP-40,
0.2 mM deoxycholate) containing 1% formaldehyde and 0.2%
glutaraldehyde and then washed three times in X-gal buffer.
Explants were stained overnight at 37°C in X-gal buffer containing 5 mM each potassium ferricyanide/potassium ferrocyanide,
0.5 mg/ml X-gal, followed by three washes in X-gal wash buffer,
and post-fixed in 4% paraformaldehyde for 2 hr. Kidney explants
were again washed three times in X-gal buffer and then either
stored as whole mounts or processed for sectioning.
Detecting cell death Cultures were incubated in a 2% solution of TOPRO-1 (Molecular Probes) in Ham’s F12 (Sigma) for
30 min at 37°C. Labeled tissues were then washed in large volumes of Ham’s F12 at 37°C for 15–30 min. Samples were
mounted on slides in Ham’s F12, and labeled cells were detected
using a fluorescein filter set on a Leitz DMR microscope.
DiI labeling DiI (Molecular Probes) was dissolved in ethanol
according to the manufacturer’s instructions. A glass microinjection pipette was used to place a small amount of dye into the
explant. Explants were cultured for an additional 2 days. Fluorescent signal was detected using a rhodamine filter set.
In situ hybridization
Histology Explants on filters were fixed in 4% paraformaldehyde/PBS or Bouin’s fixative at 4°C overnight, followed by dehydration through a graded ethanol series. The material was
cleared in xylenes or n-butanol and embedded in Fibrowax
(BDH). Samples were sectioned at 5 µm and sections collected
on Tespa-treated glass slides. Sections for histology were
stained with hematoxylin and eosin using standard procedures.
In situ hybridization Section in situ hybridization (Jones et al.
1991) and whole-mount in situ hybridization (Wall and Hogan
1995) were performed as described. Probes specific for Pax2
(Dressler et al. 1990), Wnt4 (Stark et al. 1994), WT1 (Kreidberg et
al. 1993), BF2 (Hatini et al. 1996), Bmp7 (Dudley and Robertson
1997), and Fgfr1 and Fgfr2 (Orr-Urtreger et al. 1991) were used as
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described. Sections were photographed using a Leitz DMR microscope and Fujichrome Velvia color slide film or TechPan
black and white film.
Immunohistochemistry For analysis of epithelial development, whole kidneys or explants were fixed in methanol at
−20°C then rehydrated in PBS + 0.1% Tween 20 (PBT). Samples
were blocked in 10% sheep serum/PBT for 1 hr then incubated
in 1:400 rabbit anti-mouse laminin antibody (Sigma) in 1% serum/PBT overnight at 4°C with rocking. The next day, samples
were washed extensively with PBT followed by an overnight
wash at 4°C. The primary antibody was detected using a Texas
Red-conjugated goat anti-rabbit secondary antibody at 1:400 in
PBT for 4 hr. Samples were washed extensively at room temperature then overnight at 4°C. Cultures were mounted in 90%
glycerol containing 1 mg/ml p-phenylenediamine (Sigma).
Staining was visualized using a rhodamine filter set on a Leitz
DMR microscope. Images were captured on Ektachrome Elite II
400 ASA film.

Acknowledgments
We thank T. Kuber Sampath for generously supplying recombinant protein; Kimberly Tremblay for critical reading of the
manuscript; members of the Robertson laboratory for useful
discussions; and Patti Lewko and Joe Rocca for expert animal
care. This work was supported by grants to E.J.R. from the National Institutes of Health (NIH). R.E.G. was supported by a
postdoctoral fellowship from the NIH.
The publication costs of this article were defrayed in part by
payment of page charges. This article must therefore be hereby
marked ‘advertisement’ in accordance with 18 USC section
1734 solely to indicate this fact.

References
Aufderheide, E., R. Chiquet-Ehrismann, and P. Ekblom. 1987.
Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J. Cell
Biol. 105: 599–608.
Barasch, J., J. Qiao, G. McWilliams, D. Chen, J.A. Oliver, and D.
Herzlinger. 1997. Ureteric bud cells secrete multiple factors,
including bFGF, which rescue renal progenitors from apoptosis. Am. J. Physiol. 273 F757–767.
Cancilla, B., J. Cauchi, B. Key, V. Nurcombe, D. Alcorn, and J.
Bertram. 1996. Immunolocalization of fibroblast growth factor-1 and -2 in the embryonic rat kidney. Nephrology 2: 167–
174.
Coles, H.S.R., J.F. Burne, and M.C. Raff. 1993. Large-scale normal cell death in developing rat kidney and its reduction by
epidermal growth factor. Development 118: 969–981.
Davies, J.A. and D.R. Garrod. 1995. Induction of early stages of
kidney tubule differentiation by lithium ions. Dev. Biol.
167: 50–60.
Dressler, G.R., U. Deutsch, K. Chowdhury, H.O. Nornes, and P.
Gruss. 1990. Pax2, a new murine paired-box containing gene
and its expression in the developing excretory system. Development 109: 787–795.
Dudley, A., K. Lyons, and E.J. Robertson. 1995. A requirement
for bone morphogenetic protein-7 during development of the
mammalian kidney and eye. Genes & Dev. 9: 2795–2807.
Dudley, A.T. and E.J. Robertson. 1997. Overlapping expression
domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient
embryos. Dev. Dynamics 208: 349–362.

1612

GENES & DEVELOPMENT

Ericson, J., S. Norlin, T.M. Jessell, and T. Edlund. 1998. Integrated FGF and BMP signaling controls the progression of
progenitor cell differentiation and the emergence of pattern
in the embryonic anterior pituitary. Development 125:
1005–1015.
Godin, R.E., N. Takaesu, E.J. Robertson, and A.T. Dudley. 1998.
Regulation of Bmp7 expression during kidney development.
Development 125: 3473–3482.
Gossens, C.L. and B.R. Unsworth. 1972. Evidence for a two-step
mechanism operating during in vitro mouse kidney tubulogenesis. J. Embryol. Exp. Morphol. 28: 615–631.
Gurdon, J.B. 1988. A community effect in animal development.
Nature 336: 772–774.
Hatini, V., S.O. Huh, D. Herzlinger, V.C. Soares, and E. Lai.
1996. Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of a winged-helix
transcription factor BF2. Genes & Dev. 10: 1467–1478.
Jones, C.M., K.M. Lyons, and B.L.M. Hogan. 1991. Involvement
of bone morphogenetic protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development
111: 531–542.
Koseki, C., D. Herzlinger, and Q. Al-Awqati. 1992. Apoptosis in
metanephric development. J. Cell Biol. 119: 1327–1333.
Kreidberg, J.A., H. Sariola, J.M. Loring, M. Maeda, J. Pelletier, D.
Housman, and R. Jaenisch. 1993. WT1 is required for early
kidney development. Cell 74: 679–691.
Kretzschmar, M. and J. Massagué. 1998. SMADs: Mediators and
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